Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth.
Braux J, Jourdain ML, Guillaume C, Untereiner V, Piot O, Baehr A, Klymiuk N, Winter N, Berri M, Buzoni-Gatel D, Caballero I, Guillon A, Si-Tahar M, Jacquot J, Velard F. Braux J, et al. Among authors: jacquot j. J Cyst Fibros. 2020 May;19(3):466-475. doi: 10.1016/j.jcf.2019.10.023. Epub 2019 Nov 29. J Cyst Fibros. 2020. PMID: 31787573 Free article.
Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
Jourdain ML, Sergheraert J, Braux J, Guillaume C, Gangloff SC, Hubert D, Velard F, Jacquot J. Jourdain ML, et al. Among authors: jacquot j. Biochim Biophys Acta Mol Basis Dis. 2021 Mar 1;1867(3):166010. doi: 10.1016/j.bbadis.2020.166010. Epub 2020 Nov 11. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33188942 Free article. Clinical Trial.
Bone health in cystic fibrosis: use of oral bisphosphonates.
Le Henaff C, Velard F, Jacquot J. Le Henaff C, et al. Among authors: jacquot j. Lancet Respir Med. 2013 Jul;1(5):349-50. doi: 10.1016/S2213-2600(13)70096-1. Epub 2013 Jun 2. Lancet Respir Med. 2013. PMID: 24429188 No abstract available.
Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.
Velard F, Delion M, Le Henaff C, Guillaume C, Gangloff S, Jacquot J, Tabary O, Touqui L, Barthes F, Sermet-Gaudelus I. Velard F, et al. Among authors: jacquot j. Am J Respir Crit Care Med. 2014 Mar 15;189(6):746-8. doi: 10.1164/rccm.201312-2144LE. Am J Respir Crit Care Med. 2014. PMID: 24628315 No abstract available.
Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?
Velard F, Delion M, Lemaire F, Tabary O, Guillaume C, Le Pimpec Barthès F, Touqui L, Gangloff S, Sermet-Gaudelus I, Jacquot J. Velard F, et al. Among authors: jacquot j. Eur Respir J. 2015 Mar;45(3):845-8. doi: 10.1183/09031936.00174014. Epub 2014 Nov 27. Eur Respir J. 2015. PMID: 25431270 Free article. No abstract available.
329 results